Disulfide With Synthetic Human Pr-1283233 Light Chain

Disulfide With Synthetic Human Pr-1283233 Light Chain Uses, Dosage, Side Effects, Food Interaction and all others data.

Disulfide With Synthetic Human Pr-1283233 Light Chain is under investigation in clinical trial NCT03368859 (A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab).

Trade Name Disulfide With Synthetic Human Pr-1283233 Light Chain
Generic Dilpacimab
Dilpacimab Other Names Dilpacimab, Immunoglobulin, anti-(notch ligand dll4/vascular endothelial growth factor) (synthetic human pr-1283233 heavy chain), disulfide with synthetic human pr-1283233 light chain, dimer
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Disulfide With Synthetic Human Pr-1283233 Light Chain
Disulfide With Synthetic Human Pr-1283233 Light Chain

Innovators Monograph

You find simplified version here Disulfide With Synthetic Human Pr-1283233 Light Chain


*** Taking medicines without doctor's advice can cause long-term problems.
Share